Keenova

Unverified

ManufacturerDublin, Ireland (global HQ); US corporate offices Bridgewater, NJ; Malvern, PA; Hazelwood, MO

Overview

Keenova is a U.S.-focused branded therapeutics company serving patients with rare or unaddressed conditions. It formed when Mallinckrodt combined with Endo (July 31, 2025) and spun off the generics business as Par Health (November 10, 2025). Its flagship products are Acthar Gel and XIAFLEX, alongside INOmax, Terlivaz and Supprelin LA, across immunology, urology and men's health, orthopedics, critical care and pediatric endocrinology. It promotes directly to physicians in offices, hospitals and ambulatory surgery centers with over 300 sales representatives.

Hiring snapshot

Hiring by specialty

  • Immunology12
  • Nephrology3
  • Ophthalmology2
  • Rare disease2
  • Respiratory1
  • Urology1

Open roles

Newest first, from Keenova’s careers page.

See all 26 roles →

Divisions

Division information is pending company verification.Once Keenova claims its page, you will see each division, who it calls on and how it pays.

Claim your page

More from Keenova

These sections fill in when Keenova claims and verifies its page.

Life at KeenovaPhotos, stories and culture. Not added yet.
BenefitsNot added yet.
Is this your company? Claim your page →